Gene Page: ANXA2
Summary ?
GeneID | 302 |
Symbol | ANXA2 |
Synonyms | ANX2|ANX2L4|CAL1H|HEL-S-270|LIP2|LPC2|LPC2D|P36|PAP-IV |
Description | annexin A2 |
Reference | MIM:151740|HGNC:HGNC:537|Ensembl:ENSG00000182718|HPRD:01061|Vega:OTTHUMG00000132763 |
Gene type | protein-coding |
Map location | 15q22.2 |
Pascal p-value | 0.17 |
Sherlock p-value | 5.752E-5 |
Fetal beta | 0.823 |
eGene | Myers' cis & trans |
Support | STRUCTURAL PLASTICITY CompositeSet Ascano FMRP targets |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
PMID:cooccur | High-throughput literature-search | Systematic search in PubMed for genes co-occurring with SCZ keywords. A total of 3027 genes were included. | |
Literature | High-throughput literature-search | Co-occurance with Schizophrenia keywords: schizophrenia,schizophrenias | Click to show details |
Network | Shortest path distance of core genes in the Human protein-protein interaction network | Contribution to shortest path in PPI network: 0.0983 |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs17131472 | chr1 | 91962966 | ANXA2 | 302 | 0.01 | trans | ||
rs546975 | chr1 | 91963738 | ANXA2 | 302 | 0.05 | trans | ||
rs2839839 | chr2 | 51691483 | ANXA2 | 302 | 0.15 | trans | ||
rs2922180 | chr3 | 125280472 | ANXA2 | 302 | 0 | trans | ||
rs2971271 | chr3 | 125450402 | ANXA2 | 302 | 0.06 | trans | ||
rs2976809 | chr3 | 125451738 | ANXA2 | 302 | 8.874E-4 | trans | ||
rs10050805 | chr5 | 30805352 | ANXA2 | 302 | 0 | trans | ||
rs837115 | chr5 | 40736290 | ANXA2 | 302 | 0.14 | trans | ||
rs16894149 | chr5 | 61013724 | ANXA2 | 302 | 0.02 | trans | ||
rs6449550 | chr5 | 61034312 | ANXA2 | 302 | 0.03 | trans | ||
rs17135501 | chr6 | 2704474 | ANXA2 | 302 | 0.03 | trans | ||
rs17135521 | chr6 | 2707631 | ANXA2 | 302 | 0.03 | trans | ||
snp_a-1787926 | 0 | ANXA2 | 302 | 0.03 | trans | |||
rs6934246 | chr6 | 35154494 | ANXA2 | 302 | 0.03 | trans | ||
rs6455226 | chr6 | 67930295 | ANXA2 | 302 | 0 | trans | ||
rs2199402 | chr8 | 9201002 | ANXA2 | 302 | 0 | trans | ||
rs2169384 | chr8 | 9216985 | ANXA2 | 302 | 0.12 | trans | ||
rs1381350 | chr8 | 9217194 | ANXA2 | 302 | 0.18 | trans | ||
rs7841407 | chr8 | 9243427 | ANXA2 | 302 | 2.439E-4 | trans | ||
rs680372 | chr8 | 36999626 | ANXA2 | 302 | 0.09 | trans | ||
rs2061799 | chr9 | 97795003 | ANXA2 | 302 | 0 | trans | ||
rs4743989 | chr9 | 97859191 | ANXA2 | 302 | 0.13 | trans | ||
rs4514358 | chr10 | 43861923 | ANXA2 | 302 | 0.03 | trans | ||
rs7081666 | chr10 | 47673800 | ANXA2 | 302 | 0.02 | trans | ||
rs1159612 | chr10 | 85329057 | ANXA2 | 302 | 0.11 | trans | ||
rs11199997 | chr10 | 85456823 | ANXA2 | 302 | 0.18 | trans | ||
rs11820030 | chr11 | 76133564 | ANXA2 | 302 | 0.13 | trans | ||
rs17134872 | chr11 | 76139845 | ANXA2 | 302 | 0.08 | trans | ||
rs11236774 | chr11 | 76234952 | ANXA2 | 302 | 0.08 | trans | ||
rs11049036 | chr12 | 27650292 | ANXA2 | 302 | 0.1 | trans | ||
rs10879027 | chr12 | 70237156 | ANXA2 | 302 | 0.06 | trans | ||
rs9529974 | chr13 | 72821935 | ANXA2 | 302 | 0.12 | trans | ||
rs17073665 | chr13 | 81541961 | ANXA2 | 302 | 0.01 | trans | ||
rs11840833 | chr13 | 94378306 | ANXA2 | 302 | 0.08 | trans | ||
rs10149864 | chr14 | 86719683 | ANXA2 | 302 | 0.09 | trans | ||
rs17244419 | chr14 | 97171074 | ANXA2 | 302 | 0.18 | trans | ||
rs4987765 | chr18 | 60905021 | ANXA2 | 302 | 0.13 | trans | ||
rs11873703 | chr18 | 61448702 | ANXA2 | 302 | 0 | trans | ||
rs6095741 | chr20 | 48666589 | ANXA2 | 302 | 1.433E-5 | trans | ||
rs17191809 | chr21 | 36444778 | ANXA2 | 302 | 0.19 | trans | ||
rs5991662 | chrX | 43335796 | ANXA2 | 302 | 3.85E-4 | trans | ||
rs1545676 | chrX | 93530472 | ANXA2 | 302 | 0.01 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0004859 | phospholipase inhibitor activity | IEA | - | |
GO:0004859 | phospholipase inhibitor activity | TAS | 3013422 | |
GO:0005544 | calcium-dependent phospholipid binding | IEA | - | |
GO:0005509 | calcium ion binding | IEA | - | |
GO:0008092 | cytoskeletal protein binding | IEA | - | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0001501 | skeletal system development | TAS | 7961821 | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0005576 | extracellular region | IEA | - | |
GO:0005604 | basement membrane | IEA | - | |
GO:0005625 | soluble fraction | TAS | 7961821 | |
GO:0005886 | plasma membrane | TAS | 10809787 | |
GO:0042470 | melanosome | IEA | - |
Section IV. Protein-protein interaction annotation
Interactors | Aliases B | Official full name B | Experimental | Source | PubMed ID |
---|---|---|---|---|---|
APOH | B2G1 | BG | apolipoprotein H (beta-2-glycoprotein I) | - | HPRD,BioGRID | 10809787 |
CD99 | MIC2 | MIC2X | MIC2Y | CD99 molecule | CD99 interacts with ANXA2. | BIND | 15388255 |
CEACAM1 | BGP | BGP1 | BGPI | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | - | HPRD,BioGRID | 14522961 |
CTSB | APPS | CPSB | cathepsin B | - | HPRD,BioGRID | 10777578 |
DYSF | FER1L1 | FLJ00175 | FLJ90168 | LGMD2B | dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive) | - | HPRD | 14506282 |
GRB2 | ASH | EGFRBP-GRB2 | Grb3-3 | MST084 | MSTP084 | growth factor receptor-bound protein 2 | - | HPRD,BioGRID | 7510700 |
LGALS13 | GAL13 | PLAC8 | PP13 | lectin, galactoside-binding, soluble, 13 | - | HPRD | 15009185 |
LYPLA1 | APT-1 | LPL1 | LYSOPLA | lysophospholipase I | - | HPRD,BioGRID | 1531641 |
PCNA | MGC8367 | proliferating cell nuclear antigen | - | HPRD,BioGRID | 9228079 |12171929 |
PHB | PHB1 | prohibitin | - | HPRD,BioGRID | 12628297 |
PLA1A | PS-PLA1 | PSPLA1 | phospholipase A1 member A | - | HPRD,BioGRID | 1531641 |
PLAT | DKFZp686I03148 | T-PA | TPA | plasminogen activator, tissue | - | HPRD,BioGRID | 11978811 |12468550 |
PLG | DKFZp779M0222 | plasminogen | - | HPRD | 10077593 |
PPM1B | MGC21657 | PP2C-beta-X | PP2CB | PP2CBETA | PPC2BETAX | protein phosphatase 1B (formerly 2C), magnesium-dependent, beta isoform | Affinity Capture-MS | BioGRID | 17353931 |
S100A10 | 42C | ANX2L | ANX2LG | CAL1L | CLP11 | Ca[1] | GP11 | MGC111133 | P11 | p10 | S100 calcium binding protein A10 | - | HPRD | 2148288 |8898866 |12660155 |
S100A10 | 42C | ANX2L | ANX2LG | CAL1L | CLP11 | Ca[1] | GP11 | MGC111133 | P11 | p10 | S100 calcium binding protein A10 | Co-crystal Structure | BioGRID | 9886297 |
S100A4 | 18A2 | 42A | CAPL | FSP1 | MTS1 | P9KA | PEL98 | S100 calcium binding protein A4 | - | HPRD | 15788416 |
S100A6 | 2A9 | 5B10 | CABP | CACY | PRA | S100 calcium binding protein A6 | - | HPRD | 1999197 |
SOS1 | GF1 | GGF1 | GINGF | HGF | NS4 | son of sevenless homolog 1 (Drosophila) | Reconstituted Complex | BioGRID | 7510700 |
SRC | ASV | SRC1 | c-SRC | p60-Src | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | - | HPRD,BioGRID | 11106497 |
TRPV5 | CAT2 | ECAC1 | OTRPC3 | transient receptor potential cation channel, subfamily V, member 5 | Reconstituted Complex | BioGRID | 12660155 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
HOLLMANN APOPTOSIS VIA CD40 DN | 267 | 178 | All SZGR 2.0 genes in this pathway |
LIU PROSTATE CANCER DN | 481 | 290 | All SZGR 2.0 genes in this pathway |
DEURIG T CELL PROLYMPHOCYTIC LEUKEMIA DN | 320 | 184 | All SZGR 2.0 genes in this pathway |
CHARAFE BREAST CANCER LUMINAL VS BASAL DN | 455 | 304 | All SZGR 2.0 genes in this pathway |
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN | 460 | 312 | All SZGR 2.0 genes in this pathway |
LAIHO COLORECTAL CANCER SERRATED UP | 112 | 71 | All SZGR 2.0 genes in this pathway |
BORCZUK MALIGNANT MESOTHELIOMA UP | 305 | 185 | All SZGR 2.0 genes in this pathway |
GRABARCZYK BCL11B TARGETS UP | 81 | 40 | All SZGR 2.0 genes in this pathway |
BARRIER COLON CANCER RECURRENCE UP | 42 | 28 | All SZGR 2.0 genes in this pathway |
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC UP | 185 | 126 | All SZGR 2.0 genes in this pathway |
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP | 157 | 104 | All SZGR 2.0 genes in this pathway |
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP | 44 | 30 | All SZGR 2.0 genes in this pathway |
DODD NASOPHARYNGEAL CARCINOMA UP | 1821 | 933 | All SZGR 2.0 genes in this pathway |
RODRIGUES THYROID CARCINOMA ANAPLASTIC UP | 722 | 443 | All SZGR 2.0 genes in this pathway |
ENK UV RESPONSE KERATINOCYTE UP | 530 | 342 | All SZGR 2.0 genes in this pathway |
DELYS THYROID CANCER UP | 443 | 294 | All SZGR 2.0 genes in this pathway |
CONCANNON APOPTOSIS BY EPOXOMICIN UP | 239 | 157 | All SZGR 2.0 genes in this pathway |
PATIL LIVER CANCER | 747 | 453 | All SZGR 2.0 genes in this pathway |
BORLAK LIVER CANCER EGF UP | 57 | 41 | All SZGR 2.0 genes in this pathway |
SHETH LIVER CANCER VS TXNIP LOSS PAM2 | 153 | 102 | All SZGR 2.0 genes in this pathway |
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN DN | 584 | 395 | All SZGR 2.0 genes in this pathway |
GROSS HYPOXIA VIA ELK3 AND HIF1A UP | 142 | 104 | All SZGR 2.0 genes in this pathway |
NUYTTEN EZH2 TARGETS UP | 1037 | 673 | All SZGR 2.0 genes in this pathway |
WEI MYCN TARGETS WITH E BOX | 795 | 478 | All SZGR 2.0 genes in this pathway |
LIAO METASTASIS | 539 | 324 | All SZGR 2.0 genes in this pathway |
COLIN PILOCYTIC ASTROCYTOMA VS GLIOBLASTOMA DN | 28 | 21 | All SZGR 2.0 genes in this pathway |
LEE LIVER CANCER MYC TGFA UP | 61 | 40 | All SZGR 2.0 genes in this pathway |
SANA TNF SIGNALING DN | 90 | 57 | All SZGR 2.0 genes in this pathway |
LEE LIVER CANCER ACOX1 UP | 64 | 40 | All SZGR 2.0 genes in this pathway |
SHEPARD BMYB MORPHOLINO UP | 205 | 126 | All SZGR 2.0 genes in this pathway |
LEE LIVER CANCER MYC E2F1 UP | 56 | 34 | All SZGR 2.0 genes in this pathway |
CHEOK RESPONSE TO HD MTX UP | 23 | 13 | All SZGR 2.0 genes in this pathway |
SANA RESPONSE TO IFNG DN | 85 | 56 | All SZGR 2.0 genes in this pathway |
SASAKI ADULT T CELL LEUKEMIA | 176 | 122 | All SZGR 2.0 genes in this pathway |
LEE LIVER CANCER DENA UP | 60 | 40 | All SZGR 2.0 genes in this pathway |
LEE LIVER CANCER E2F1 UP | 62 | 35 | All SZGR 2.0 genes in this pathway |
XU RESPONSE TO TRETINOIN DN | 13 | 8 | All SZGR 2.0 genes in this pathway |
IGLESIAS E2F TARGETS UP | 151 | 103 | All SZGR 2.0 genes in this pathway |
MUNSHI MULTIPLE MYELOMA UP | 81 | 52 | All SZGR 2.0 genes in this pathway |
BRUNO HEMATOPOIESIS | 66 | 48 | All SZGR 2.0 genes in this pathway |
REN ALVEOLAR RHABDOMYOSARCOMA DN | 408 | 274 | All SZGR 2.0 genes in this pathway |
IVANOVA HEMATOPOIESIS LATE PROGENITOR | 544 | 307 | All SZGR 2.0 genes in this pathway |
BROWNE HCMV INFECTION 14HR DN | 298 | 200 | All SZGR 2.0 genes in this pathway |
YAMAZAKI TCEB3 TARGETS UP | 175 | 116 | All SZGR 2.0 genes in this pathway |
NATSUME RESPONSE TO INTERFERON BETA DN | 52 | 33 | All SZGR 2.0 genes in this pathway |
BROWNE HCMV INFECTION 20HR DN | 101 | 70 | All SZGR 2.0 genes in this pathway |
BLALOCK ALZHEIMERS DISEASE UP | 1691 | 1088 | All SZGR 2.0 genes in this pathway |
GERHOLD ADIPOGENESIS DN | 64 | 44 | All SZGR 2.0 genes in this pathway |
DAZARD RESPONSE TO UV NHEK UP | 244 | 151 | All SZGR 2.0 genes in this pathway |
TAKAO RESPONSE TO UVB RADIATION DN | 98 | 67 | All SZGR 2.0 genes in this pathway |
RODWELL AGING KIDNEY NO BLOOD UP | 222 | 139 | All SZGR 2.0 genes in this pathway |
RODWELL AGING KIDNEY UP | 487 | 303 | All SZGR 2.0 genes in this pathway |
WELCSH BRCA1 TARGETS UP | 198 | 132 | All SZGR 2.0 genes in this pathway |
DAZARD RESPONSE TO UV SCC UP | 123 | 75 | All SZGR 2.0 genes in this pathway |
DAZARD UV RESPONSE CLUSTER G1 | 67 | 41 | All SZGR 2.0 genes in this pathway |
ZHONG SECRETOME OF LUNG CANCER AND MACROPHAGE | 77 | 50 | All SZGR 2.0 genes in this pathway |
LEIN MEDULLA MARKERS | 81 | 48 | All SZGR 2.0 genes in this pathway |
AMUNDSON POOR SURVIVAL AFTER GAMMA RADIATION 2G | 171 | 96 | All SZGR 2.0 genes in this pathway |
WINTER HYPOXIA METAGENE | 242 | 168 | All SZGR 2.0 genes in this pathway |
MUELLER PLURINET | 299 | 189 | All SZGR 2.0 genes in this pathway |
WANG TUMOR INVASIVENESS UP | 374 | 247 | All SZGR 2.0 genes in this pathway |
JIANG TIP30 TARGETS UP | 46 | 28 | All SZGR 2.0 genes in this pathway |
BOYLAN MULTIPLE MYELOMA C D DN | 252 | 155 | All SZGR 2.0 genes in this pathway |
GOLDRATH ANTIGEN RESPONSE | 346 | 192 | All SZGR 2.0 genes in this pathway |
RUTELLA RESPONSE TO CSF2RB AND IL4 UP | 338 | 225 | All SZGR 2.0 genes in this pathway |
RUTELLA RESPONSE TO HGF UP | 418 | 282 | All SZGR 2.0 genes in this pathway |
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN | 245 | 150 | All SZGR 2.0 genes in this pathway |
HOFFMANN PRE BI TO LARGE PRE BII LYMPHOCYTE DN | 75 | 61 | All SZGR 2.0 genes in this pathway |
HOFMANN MYELODYSPLASTIC SYNDROM LOW RISK DN | 30 | 20 | All SZGR 2.0 genes in this pathway |
CHEN METABOLIC SYNDROM NETWORK | 1210 | 725 | All SZGR 2.0 genes in this pathway |
HSIAO HOUSEKEEPING GENES | 389 | 245 | All SZGR 2.0 genes in this pathway |
MEISSNER BRAIN HCP WITH H3K4ME3 AND H3K27ME3 | 1069 | 729 | All SZGR 2.0 genes in this pathway |
ZHAN VARIABLE EARLY DIFFERENTIATION GENES UP | 15 | 9 | All SZGR 2.0 genes in this pathway |
MEISSNER NPC HCP WITH H3K4ME2 | 491 | 319 | All SZGR 2.0 genes in this pathway |
NGO MALIGNANT GLIOMA 1P LOH | 17 | 13 | All SZGR 2.0 genes in this pathway |
ZHAN MULTIPLE MYELOMA CD2 DN | 46 | 29 | All SZGR 2.0 genes in this pathway |
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 13 | 172 | 107 | All SZGR 2.0 genes in this pathway |
DAZARD UV RESPONSE CLUSTER G28 | 20 | 11 | All SZGR 2.0 genes in this pathway |
BROWNE HCMV INFECTION 2HR DN | 49 | 33 | All SZGR 2.0 genes in this pathway |
KARLSSON TGFB1 TARGETS UP | 127 | 78 | All SZGR 2.0 genes in this pathway |
LI INDUCED T TO NATURAL KILLER UP | 307 | 182 | All SZGR 2.0 genes in this pathway |
VERHAAK GLIOBLASTOMA MESENCHYMAL | 216 | 130 | All SZGR 2.0 genes in this pathway |
CHICAS RB1 TARGETS CONFLUENT | 567 | 365 | All SZGR 2.0 genes in this pathway |
DUTERTRE ESTRADIOL RESPONSE 24HR DN | 505 | 328 | All SZGR 2.0 genes in this pathway |
JOHNSTONE PARVB TARGETS 3 DN | 918 | 550 | All SZGR 2.0 genes in this pathway |
PASINI SUZ12 TARGETS DN | 315 | 215 | All SZGR 2.0 genes in this pathway |
FEVR CTNNB1 TARGETS UP | 682 | 433 | All SZGR 2.0 genes in this pathway |
KOINUMA TARGETS OF SMAD2 OR SMAD3 | 824 | 528 | All SZGR 2.0 genes in this pathway |
GOBERT OLIGODENDROCYTE DIFFERENTIATION UP | 570 | 339 | All SZGR 2.0 genes in this pathway |
SERVITJA ISLET HNF1A TARGETS UP | 163 | 111 | All SZGR 2.0 genes in this pathway |
SERVITJA LIVER HNF1A TARGETS UP | 135 | 96 | All SZGR 2.0 genes in this pathway |
PEDERSEN METASTASIS BY ERBB2 ISOFORM 7 | 403 | 240 | All SZGR 2.0 genes in this pathway |
HUANG GATA2 TARGETS UP | 149 | 96 | All SZGR 2.0 genes in this pathway |
NABA ECM AFFILIATED | 171 | 89 | All SZGR 2.0 genes in this pathway |
NABA MATRISOME ASSOCIATED | 753 | 411 | All SZGR 2.0 genes in this pathway |
NABA MATRISOME | 1028 | 559 | All SZGR 2.0 genes in this pathway |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-1/206 | 198 | 205 | 1A,m8 | hsa-miR-1 | UGGAAUGUAAAGAAGUAUGUA |
hsa-miR-206SZ | UGGAAUGUAAGGAAGUGUGUGG | ||||
hsa-miR-613 | AGGAAUGUUCCUUCUUUGCC | ||||
miR-185 | 173 | 179 | m8 | hsa-miR-185brain | UGGAGAGAAAGGCAGUUC |
miR-409-3p | 197 | 203 | m8 | hsa-miR-409-3p | CGAAUGUUGCUCGGUGAACCCCU |
miR-9 | 186 | 192 | 1A | hsa-miR-9SZ | UCUUUGGUUAUCUAGCUGUAUGA |
- SZ: miRNAs which differentially expressed in brain cortex of schizophrenia patients comparing with control samples using microarray. Click here to see the list of SZ related miRNAs.
- Brain: miRNAs which are expressed in brain based on miRNA microarray expression studies. Click here to see the list of brain related miRNAs.